Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$130,349
+$18,995 QoQ
Shares Held
518
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#4,024
of 4,176 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Navigoe, LLC holds $1,093,900 across 13 Drug Manufacturers - General names. ABBV ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
2,027 | $734,017 | |
| 2 | LLY |
ELI LILLY & Co
|
113 | $135,535 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
518 | $130,349 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
445 | $25,640 | |
| 5 | JNJ |
Johnson & Johnson
|
91 | $23,111 | |
| 6 | PFE |
Pfizer Inc
|
930 | $22,394 | |
| 7 | MRK |
Merck & Co., Inc.
|
114 | $14,649 | |
| 8 | NVS |
Novartis AG
|
23 | $3,604 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,349 | 518 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $111,354 | 512 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $116,986 | 512 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $118,548 | 512 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $92,810 | 500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $104,760 | 500 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $130,431 | 734 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||